View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Gamlen Instruments|8 February 2017

Gamlen M Series

The Gamlen M series tablet press enables the manufacture of small batches of pharmaceutical tablets.

Mseries

The Gamlen M series tablet press enables the manufacture of small batches of pharmaceutical tablets.

Easy to operate, the M series works straight out of the box, with no training is required. Users simply manufacture quality controlled tablets at the touch of a button. Producing 100-180 tablets per hour, the M series is ideal for use in a controlled good manufacturing practice (GMP) environment such as an isolator.

Key benefits

Using tiny amounts of material (down to 10mg), M series wastage rates are normally less than 1%, which saves money and precious materials. The machine can also be used in a controlled humidity environment. Users can check product quality prior to putting batches onto production presses.

Formulation comparisons, test product batches, and clinical trial materials are quick to prepare with the Gamlen M series.

Performance summary

Producing 100-180 tablets per hour and using doses as low as 10mg, the M series manufactures tablets under controlled conditions including controlled compaction rate, compaction force, temperature, and humidity (when used with a controlled humidity environment).

With a simple change of mode to hardness tester, the M series measures tablet tensile strength.

Gamlen presents a study conducted by V. Penkavova1, L. Kulaviak1, M.C. Ruzicka1, M. Puncochar, and P. Zamostny on the 'Beaking of Anisotropic Rod-Saped Particles'.
The efficiency of downstream processing of active pharmaceutical ingredients (API) can depend on their particulate properties, including size and shape.
This whitepaper described a method for performing dynamic powder compaction analysis and for measuring tensile fracture strength of tablets.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology